Our client had a specific need to develop and build a highly effective team of key account managers (KAMs) and Medical Science Liaisons (MSLs) in the UK and EU4 with experience and expertise in the relevant rare disease areas.
Following in-depth scoping meetings, Inizio Engage worked closely with the client to define the optimum levels of support for commercial endeavors as well as providing KOLs with peer-to-peer level medical expertise.
Recruiting MSLs with the appropriate background can be a challenge for any business – we delivered on this in the key European markets in time for pre-launch activities.
Inizio Engage recruited and trained KAMs with the appropriate experience and educational background to focus on specific targeted physicians in the rare disease space.
We provided the in-country infrastructure along with the above-country governance, without the need for the client to build in-house infrastructure in each market.
The partnership continues to be a success, in some countries so successful that individuals initially employed by Inizio Engage have been taken in-house.
Jump to a slide with the slide dots.
CASE STUDY (CANADA) Inizio Engage delivered a patient-first, flexible model for a once-monthly injectable launch in Canada.
Read moreCASE STUDY (CANADA) Discover how Inizio Engage transformed an underperforming sales force in Canada.
Read moreNuvera expands its data-driven solutions and strengthens its leadership team to enhance patient and HCP treatment experiences.
Read more